These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. α-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism. Yun SP; Kim D; Kim S; Kim S; Karuppagounder SS; Kwon SH; Lee S; Kam TI; Lee S; Ham S; Park JH; Dawson VL; Dawson TM; Lee Y; Ko HS Mol Neurodegener; 2018 Jan; 13(1):1. PubMed ID: 29310663 [TBL] [Abstract][Full Text] [Related]
7. Glucocerebrosidase enzyme activity in GBA mutation Parkinson's disease. Ortega RA; Torres PA; Swan M; Nichols W; Boschung S; Raymond D; Barrett MJ; Johannes BA; Severt L; Shanker V; Hunt AL; Bressman S; Pastores GM; Saunders-Pullman R J Clin Neurosci; 2016 Jun; 28():185-6. PubMed ID: 26857292 [TBL] [Abstract][Full Text] [Related]
8. The association between ß-glucocerebrosidase mutations and parkinsonism. Swan M; Saunders-Pullman R Curr Neurol Neurosci Rep; 2013 Aug; 13(8):368. PubMed ID: 23812893 [TBL] [Abstract][Full Text] [Related]
10. The link between the GBA gene and parkinsonism. Sidransky E; Lopez G Lancet Neurol; 2012 Nov; 11(11):986-98. PubMed ID: 23079555 [TBL] [Abstract][Full Text] [Related]
11. Fibroblasts from idiopathic Parkinson's disease exhibit deficiency of lysosomal glucocerebrosidase activity associated with reduced levels of the trafficking receptor LIMP2. Thomas R; Moloney EB; Macbain ZK; Hallett PJ; Isacson O Mol Brain; 2021 Jan; 14(1):16. PubMed ID: 33468204 [TBL] [Abstract][Full Text] [Related]
12. Glucocerebrosidase Mutations Cause Mitochondrial and Lysosomal Dysfunction in Parkinson's Disease: Pathogenesis and Therapeutic Implications. Zheng W; Fan D Front Aging Neurosci; 2022; 14():851135. PubMed ID: 35401150 [TBL] [Abstract][Full Text] [Related]
13. Lysosomal functions and dysfunctions: Molecular and cellular mechanisms underlying Gaucher disease and its association with Parkinson disease. Horowitz M; Braunstein H; Zimran A; Revel-Vilk S; Goker-Alpan O Adv Drug Deliv Rev; 2022 Aug; 187():114402. PubMed ID: 35764179 [TBL] [Abstract][Full Text] [Related]
14. Viable neuronopathic Gaucher disease model in Medaka (Oryzias latipes) displays axonal accumulation of alpha-synuclein. Uemura N; Koike M; Ansai S; Kinoshita M; Ishikawa-Fujiwara T; Matsui H; Naruse K; Sakamoto N; Uchiyama Y; Todo T; Takeda S; Yamakado H; Takahashi R PLoS Genet; 2015 Apr; 11(4):e1005065. PubMed ID: 25835295 [TBL] [Abstract][Full Text] [Related]
15. The association between mutations in the lysosomal protein glucocerebrosidase and parkinsonism. DePaolo J; Goker-Alpan O; Samaddar T; Lopez G; Sidransky E Mov Disord; 2009 Aug; 24(11):1571-8. PubMed ID: 19425057 [TBL] [Abstract][Full Text] [Related]
16. Modulation of β-glucocerebrosidase increases α-synuclein secretion and exosome release in mouse models of Parkinson's disease. Papadopoulos VE; Nikolopoulou G; Antoniadou I; Karachaliou A; Arianoglou G; Emmanouilidou E; Sardi SP; Stefanis L; Vekrellis K Hum Mol Genet; 2018 May; 27(10):1696-1710. PubMed ID: 29547959 [TBL] [Abstract][Full Text] [Related]
17. Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations. Alcalay RN; Levy OA; Waters CC; Fahn S; Ford B; Kuo SH; Mazzoni P; Pauciulo MW; Nichols WC; Gan-Or Z; Rouleau GA; Chung WK; Wolf P; Oliva P; Keutzer J; Marder K; Zhang X Brain; 2015 Sep; 138(Pt 9):2648-58. PubMed ID: 26117366 [TBL] [Abstract][Full Text] [Related]
18. The role of glucocerebrosidase in Parkinson disease pathogenesis. Gegg ME; Schapira AHV FEBS J; 2018 Oct; 285(19):3591-3603. PubMed ID: 29385658 [TBL] [Abstract][Full Text] [Related]
20. A double-hit in vivo model of GBA viral microRNA-mediated downregulation and human alpha-synuclein overexpression demonstrates nigrostriatal degeneration. Polissidis A; Koronaiou E; Nikolopoulou G; Viel C; Nikatou M; Bogiongko M; Sardi SP; Xilouri M; Vekrellis K; Stefanis L Neurobiol Dis; 2022 Feb; 163():105612. PubMed ID: 34995756 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]